{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:46:16Z","timestamp":1771015576917,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.3816\/clc.2008.n.043","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T21:54:54Z","timestamp":1222898094000},"page":"280-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Weekly Paclitaxel in Elderly Patients (Aged \u2265 70 Years) with Advanced Non\u2013Small-Cell Lung Cancer: An Alternative Choice? Results of a Phase II Study"],"prefix":"10.3816","volume":"9","author":[{"given":"David","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Dennetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Alessandroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano Luzi","family":"Fedeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Giordani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Casadei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLC.2008.n.043_bib1","first-page":"71","article-title":"Cancer Statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.3816\/CLC.2008.n.043_bib2","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/S0959-8049(97)10050-8","article-title":"Lung cancer in the elderly","volume":"33","author":"Gridelli","year":"1997","journal-title":"Eur J Cancer"},{"issue":"suppl 7","key":"10.3816\/CLC.2008.n.043_bib3","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/1097-0142(19941001)74:7+<2101::AID-CNCR2820741718>3.0.CO;2-M","article-title":"The National Cancer Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis in the elderly","volume":"74","author":"Havlik","year":"1994","journal-title":"Cancer"},{"key":"10.3816\/CLC.2008.n.043_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a metaanalysis using updated data on individual patients from 52 randomised trials","volume":"311","author":"Non-Small Cell Lung Cancer Collaborative Group","year":"1995","journal-title":"BMJ"},{"key":"10.3816\/CLC.2008.n.043_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2004.09.053","article-title":"American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer: update 2003","volume":"22","author":"Pfister","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLC.2008.n.043_bib6","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1200\/JCO.2005.00.224","article-title":"Treatment of advanced non-small cell lung cancer in the elderly: results of an international expert panel","volume":"23","author":"Gridelli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLC.2008.n.043_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jnci\/91.1.66","article-title":"Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer","volume":"91","author":"Elderly Lung Cancer Vinorelbine Italian Study Group","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLC.2008.n.043_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jnci\/95.5.362","article-title":"Chemotherapy for elderly patients with advanced non-small cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial","volume":"95","author":"Gridelli","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLC.2008.n.043_bib9","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.06.1044","article-title":"Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)","volume":"24","author":"Kudoh","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLC.2008.n.043_bib10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1634\/theoncologist.4-5-408","article-title":"Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer","volume":"4","author":"Socinsky","year":"1999","journal-title":"The Oncologist"},{"key":"10.3816\/CLC.2008.n.043_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00685842","article-title":"Cell kill kinetics and cell cycles effects of Taxol on human and hamster ovarian cancer cell lines","volume":"32","author":"Lopes","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.3816\/CLC.2008.n.043_bib12","first-page":"6938","article-title":"Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs","volume":"62","author":"Bocci","year":"2002","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2008.n.043_bib13","first-page":"3942","article-title":"A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer","volume":"7","author":"Fidias","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2008.n.043_bib14","first-page":"267b","article-title":"A phase II study of weekly paclitaxel (Taxol) in stage IIIB, IV or relapsed after local therapy, non-small cell lung cancer (NSCLC) patients with a performance status of 2 and\/or \u2265 70 years of age, with Paraplatin administered at disease progression","volume":"20","author":"Garbo","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLC.2008.n.043_bib15","first-page":"258b","article-title":"A phase II trial of weekly paclitaxel in elderly patients or those with decreased performance status with advanced non-small cell lung cancer","volume":"20","author":"West","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLC.2008.n.043_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002800000143","article-title":"Retrospective comparison of toxicity and efficacy in phase II trials of 3-h infusion of paclitaxel for patients aged 70 years of age or older and patients under 70 years of age","volume":"46","author":"Nakamura","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.3816\/CLC.2008.n.043_bib17","first-page":"734","article-title":"Weekly paclitaxel in non-small cell lung cancer (NSCLC): Results in older or frail patients. A Spanish Lung Cancer Group Trial (GECP 00-02)","volume":"23","author":"Massut\u00ec","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLC.2008.n.043_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/02841860600833178","article-title":"Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel","volume":"46","author":"Juan","year":"2007","journal-title":"Acta Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411708531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411708531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:02:55Z","timestamp":1761505375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730411708531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1525730411708531"],"URL":"https:\/\/doi.org\/10.3816\/clc.2008.n.043","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weekly Paclitaxel in Elderly Patients (Aged \u2265 70 Years) with Advanced Non\u2013Small-Cell Lung Cancer: An Alternative Choice? Results of a Phase II Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLC.2008.n.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}